Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Mangalore

Indian Journal of Medical Sciences

Volumn 64, Issue 3, 2010, Pages 99-103

  Bhat, Sevitha ^a   Radhakrishna, M ^b   Kotian, Mohan ^b   Rao, Sunil ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b YENEPOYA MEDICAL COLLEGE   (India)

Author keywords

Drug resistance; isoniazid; multi drug resistant tuberculosis; rifampicin

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPECIES DIFFERENTIATION; SPUTUM CULTURE;

ANTITUBERCULAR AGENTS; ETHAMBUTOL; HUMANS; INDIA; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SPUTUM; STREPTOMYCIN; TUBERCULOSIS, PULMONARY;

EID: 84862072959     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.95928     Document Type: Article

References (16)

1. Cohn DL, Bustreo F, Raviglione MC. Drug resistant Tuberculosis. Review of world-widesituation and WHO/IUATLD Global Surveillance Project. Clin Infect Dis 1997;24(Suppl):121-30.
2. Prasad R. MDR-TB-Current status. Indian J Tub 2005;52:121-36.
3. Van Rie A, Enarson D. XDR-TB, an indicator of public health negligence. Lancet 2006;368:1554-6. (Pubitemid 44691898)
4. Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global Surveillance for antituberculosis drug resistance; 1994-1997. N Engl J Med 1998;338:1641-9.
5. Smithwick RW. Laboratory manual for acid fast microscopy. 2nd ed. Atlanta: Centre for Disease Control; 1975.
6. Harries A, Maher D, Graham S. TB/HIV A Clinical Manual. 2nd ed. Geneva: WHO/HTM/TB/2004. p. 51-3.
7. Kent TK, Kubica GP. Public health mycobacteriology. A guide for level III Laboratory. Atlanta: Centre for Disease Control; 1985.
8. Witebsky FG, Kruczak-Filipor P. Identification of Mycobacteria by conventional methods. Clin Lab Med 1996;16:569-601. (Pubitemid 26278076)
9. Allen BW,Baker FJ. In Mycobacteria - Isolation, Identification and sensitivity testing. Allen and Baker, editors. London: Butterworth and Co.; 1968. p.35.
10. Gupta RR, Singhal B, Sharma TN, Gupta RB, Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Ind. J Med. Res 1993; 97: 102-103. (Pubitemid 23239816)
11. Neville K, Bromberg A, Bromberg R, Bonk S, Hanna BA, Rom WN. The third epidemic-multidrugresistanttuberculosis. Chest 1994;105:45-8.
12. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with Pulmonary Tuberculosis resistant toH and R. N Engl J Med 1993;328:527-32. (Pubitemid 23053828)
13. Chowgule RV, Deodar L. Pattern of secondary acquired drug resistance to antituberculosis drug in Mumbai, India. Indian J Chest Dis Allied Sci 1998;40:23-31.
14. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001;344:1294-303. (Pubitemid 32377203)
15. Paramasivan CN, Bhaskaran K, Venkatraman, Chandrashekharan V. Surveillance of drug resistance in tuberculosis in Tamilnadu. Indian JTuberc 2000;47:27-33.
16. Sphia V, Balasangameshwara VH, Kumar P. Initial drug resistance among TB patients under DOTS programme in Bangalore city. Indian J Tuberc 2004;52:17-21.